Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70 | 20 | 20 | 3 | N/A |
| Receivables | 0 | 1 | 0 | 0 | N/A |
| Other current assets | 40 | 19 | 20 | 27 | 0 |
| TOTAL | $110 | $40 | $40 | $30 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 140 | 130 | 110 | 110 | N/A |
| Other Non-Current Assets | 210 | 210 | 210 | 210 | 0 |
| TOTAL | $350 | $340 | $320 | $320 | $N/A |
| Total Assets | $390 | $300 | $290 | $290 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 7 | 990 | 980 | 0 |
| Accrued Expenses | 580 | 560 | 540 | 70 | N/A |
| Other current liabilities | 7 | 10 | 240 | 810 | N/A |
| TOTAL | $1,750 | $1,730 | $3,480 | $3,280 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,750 | $1,730 | $3,480 | $3,280 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 32,911 |
| Common Shares | 10 | 50 | 50 | 30 | N/A |
| Retained earnings | -28,080 | -26,910 | -26,220 | -25,760 | N/A |
| Other shareholders' equity | 0 | 0 | 10 | 10 | 0 |
| TOTAL | $-1,360 | $-1,430 | $-3,180 | $-2,990 | $N/A |
| Total Liabilities And Equity | $390 | $300 | $300 | $290 | $0 |